Screener
Ultragenyx Pharmaceutical RARE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's free cash flow?
- Ultragenyx Pharmaceutical (RARE) reported free cash flow of -$98M in Q2 2026.
- How has Ultragenyx Pharmaceutical's free cash flow changed year-over-year?
- Ultragenyx Pharmaceutical's free cash flow increased by 12.5% year-over-year, from -$112M to -$98M.
- What is the long-term trend for Ultragenyx Pharmaceutical's free cash flow?
- Over 4 years (2021 to 2025), Ultragenyx Pharmaceutical's free cash flow has grown at a 3.5% compound annual growth rate (CAGR), from -$411.79M to -$472M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Ultragenyx Pharmaceutical's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude